Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
14464-29-0
29921-57-1 | Isopropyl bromoacetate | AA003R1Z | MFCD00009886
1499-55-4 | L-Glutamic acid 5-methyl ester | AA003R74 | MFCD00002632
60871-83-2 | Magnesium trifluoromethanesulfonate | AA003RCN | MFCD00042601
1346597-55-4 | Methyl 1-acetyl-6-bromo-1h-indazole-4-carboxylate | AA003RH1 | MFCD20491414
5445-19-2 | Methyl 2-bromohexanoate | AA003RKD | MFCD00045038
51329-15-8 | Methyl 3,5-dibromobenzoate | AA003RNM | MFCD00082648
3795-79-7 | Methyl 4-(methylthio)benzoate | AA003RR6 | MFCD01313010
1133115-60-2 | Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate | AA003RUN | MFCD11855876
66-27-3 | Methyl methanesulfonate | AA003RY6 | MFCD00007557
791-29-7 | METHYLTRIPHENYLSILANE | AA003S1U | MFCD00041325